Monterey Bio Acquisition
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Monterey Bio Acquisition's balance sheet done over the years? Its assets were worth $21,418,521 last year, which is less than in the previous period. 8% of Monterey Bio Acquisition’s total assets is currently financed by debt. Its liabilities reached the amount of $1,678,124, which means an increase by 487% compared compared to last year.

Debt to Assets

Monterey Bio Acquisition Corporation (NASDAQ:MTRY): Debt to assets
2020 25000 1K 4%
2021 117354491 285.80K 0.24%
2022 21418521 1.67M 7.83%

MTRY Balance Sheet (2020 – 2022)

2022 2021 2020
Assets
Current assets:
Cash and cash equivalents
145.81K510.81K25K
Short term investments
21.02M00
Net receivables
030K0
Inventory
000
Other current assets
243.00K388.91K0
Total current assets
388.81K929.72K25K
Non-current assets:
Property, Plant and Equipment
000
Goodwill
000
Intangible assets
000
Long term investments
000
Other non-current assets
21.02M116.42M0
Total non-current assets
21.02M116.42M0
Total assets
21.41M117.35M25K
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
700K00
Short term debt
000
Total current liabilities
1.67M285.80K1K
Non-current liabilities:
Long term debt
000
Deferred tax
000
Other non-current liabilities
700K00
Total non-current liabilities
700K00
Total liabilities
1.67M285.80K1K
Data sourceData source